Clinical ink announces GlucoseReady™
23 avr. 2024 08h00 HE
|
Clinical Ink
Winston Salem, NC, April 23, 2024 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, today announced the launch of GlucoseReady™, a fully integrated GCP compliant digital...
Clinical ink Expands Patient Engagement Solutions with Behavioral Diagnostic Tool SPUR™
13 nov. 2023 14h13 HE
|
Clinical Ink
Winston Salem, NC, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, is expanding its patient engagement suite with the inclusion of the SPUR behavioral...
Nature Publishes Work Demonstrating Clinical ink Technology Sensitivity to Parkinson’s Disease
15 mai 2023 13h30 HE
|
Clinical Ink
Winston Salem, NC, May 15, 2023 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, announces the publication of “Using a smartwatch and smartphone to assess early...
Feel Therapeutics Selected to Join Johnson & Johnson Innovation–JLABS to Catalyze their Vision of Digital Precision Medicine in Mental Health
09 mai 2023 08h30 HE
|
Feel Therapeutics
SAN FRANCISCO, May 09, 2023 (GLOBE NEWSWIRE) -- Feel Therapeutics, a leading digital precision medicine company, is proud to announce that it has been accepted into Johnson & Johnson...
Ad Scientiam Launches Programs to Develop Digital Biomarkers for Chronic Neurological Diseases
28 févr. 2023 08h00 HE
|
Ad Scientiam
PARIS, FRANCE, Feb. 28, 2023 (GLOBE NEWSWIRE) -- On Rare Disease Day, Ad Scientiam, a leader in digital biomarkers, announced the launch of two ambitious programs to develop and validate novel...
Ad Scientiam Launches Programs to Develop Digital Biomarkers for Chronic Neurological Diseases
28 févr. 2023 08h00 HE
|
Ad Scientiam
PARIS, FRANCE, Feb. 28, 2023 (GLOBE NEWSWIRE) -- On Rare Disease Day, Ad Scientiam, a leader in digital biomarkers, announced the launch of two ambitious programs to develop and validate novel...
Clinical ink Selected for Global Late Phase Parkinson’s Disease Programs
15 déc. 2022 08h42 HE
|
Clinical Ink
Horsham, PA, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Clinical ink, a global life science technology company, has partnered with a leading biopharmaceutical organization focused on Parkinson’s Disease...
Clinical ink Selected for Global Late Phase Parkinson’s Disease Programs
14 déc. 2022 10h47 HE
|
Clinical Ink
Horsham, PA, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Horsham, Pa.; December 14, 2022 — Clinical ink, a global life science technology company, has partnered with a leading biopharmaceutical organization...
Feel Therapeutics Launches its Ground-breaking Digital Precision Medicine Platform to Enable the Era of Precision Neuroscience and Psychiatry
22 sept. 2022 07h41 HE
|
Feel Therapeutics
SAN FRANCISCO, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Feel Therapeutics Inc., a leading company developing digital biomarkers and therapeutics to bring objective measurement and data in mental health,...
Healios AG Announces Addition of Anna Walz to Board of Directors
12 avr. 2022 14h00 HE
|
Healios AG
BASEL, Switzerland, April 12, 2022 (GLOBE NEWSWIRE) -- Healios AG, a MedTech company focused on developing and validating digital biomarkers since 2014, announced that Anna Walz has been appointed...